Last reviewed · How we verify
NCT07079449
Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome
NA trial testing Dry Needling in Myofascial Pain Syndrome in 75 participants. Completed in 4 August 2025.
4 August 2025
Quick facts
| Lead sponsor | Sümer Münevveroğlu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 May 2025 |
| Primary completion | 4 August 2025 |
| Estimated completion | 4 August 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Dry Needling
- Lidocaine Hydrochloride (Lidocaine Hydrochloride) — full drug profile →
- Mepivacaine Hydrochloride — full drug profile →
Conditions studied
- Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
- Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
- Facial Pain — all drugs for Facial Pain →
Sponsor
Sümer Münevveroğlu
Who can join
Adults 18 to 64, any sex, with Myofascial Pain Syndrome or Temporomandibular Joint Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized clinical trial will aim to compare the effectiveness of dry needling, lidocaine injection, and mepivacaine injection in the treatment of myofascial pain in the masticatory muscles. A total of 75 participants with bilateral active trigger points in the masseter and/or temporalis muscles will be enrolled and randomly assigned to three intervention groups. Each participant will receive weekly treatments for three weeks. Pain levels, depressive symptoms, and temporomandibular disorder severity will be assessed using the Visual Analog Scale, the Beck Depression Inventory, and the Fonseca Anamnestic Index. Outcome measures will be recorded at baseline and one week after the final treatment session. The primary objective of this study is to determine which intervention provides the greatest improvement in myofascial pain symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07079449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dry Needling
Trials testing the same drug.
- NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
- NCT07456735 — Comparison of the Effectiveness of Dry Needling Versus the Combination of Dry Needling and Local Anesthetic Injection in · Phase 4 · not yet recruiting
- NCT07270276 — The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain · NA · recruiting
- NCT07133139 — Treatment Validation for Myofascial Pain · NA · recruiting
- NCT07190768 — Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome · NA · not yet recruiting
Other recruiting trials for Myofascial Pain Syndrome
Currently open trials in the same condition.
- NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
- NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting
Other Sümer Münevveroğlu trials
Trials by the same sponsor.
- NCT07125963 — Patient-Specific vs. Conventional Positioning in Sagittal Split Ramus Osteotomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07079449 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sümer Münevveroğlu
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07079449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing